Package 72658-1254-3

{"route": ["ORAL"], "spl_id": "3e4a14d9-8d90-5f05-e063-6294a90a110e", "openfda": {"nui": ["N0000175430"], "unii": ["838F01T721"], "rxcui": ["672567", "672569", "672571", "866103"], "spl_set_id": ["de95e29f-a030-4777-a601-874500ab8e91"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Eskayef Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1254-1)", "package_ndc": "72658-1254-1", "marketing_start_date": "20251002"}, {"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1254-2)", "package_ndc": "72658-1254-2", "marketing_start_date": "20251002"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1254-3)", "package_ndc": "72658-1254-3", "marketing_start_date": "20251002"}], "brand_name": "PALIPERIDONE", "product_id": "72658-1254_3e4a14d9-8d90-5f05-e063-6294a90a110e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "72658-1254", "generic_name": "PALIPERIDONE", "labeler_name": "Eskayef Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PALIPERIDONE", "active_ingredients": [{"name": "PALIPERIDONE", "strength": "3 mg/1"}], "application_number": "ANDA218755", "marketing_category": "ANDA", "marketing_start_date": "20251002", "listing_expiration_date": "20261231"}